DAS-181

· Ansun Biopharma, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for DAS-181, covering 2009-01-08 to 2024-11-20. Get the full timeline:

Most recent: Clinical Trial Update: Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study [Phase 3]

See pricing